← Leaderboards
Hirak S. Basu
University Of Wisconsin-Madison
$1,671,898
Attributed
$3,584,203
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $912.6K · FY2006–17$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$3,584,203 · 5
By mechanism
R01$2,868,458 · 1
R43$409,558 · 2
R21$161,318 · 1
R03$144,869 · 1
Top collaborators
- David J Beebe4 shared
- Kevin William Eliceiri4 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- David J Beebe$20,083,426
- J Wand$1,193
- Nita Sahai$1,923,988
Others in their field
Top investigators on “Refractory”
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Daniel Lowenstein · Beth Israel Deaconess Medical Center$26,416,844
- Richard A. Van Etten · Immune Disease Institute, Inc.$19,396,547
- Jaideep Kapur · University Of Virginia$18,628,542
- Joren C Madsen · Massachusetts General Hospital$17,929,407
- Kenneth C Anderson · Dana-Farber Cancer Inst$17,511,211
Research focus
RefractoryReactive Oxygen SpeciesHormonesTissuesProstateMalignant Neoplasm Of ProstateAndrogensOxidationMetastatic Prostate CancerCessation Of LifePreventProductionCancer EtiologyMalignant NeoplasmsSpermidineCellsSperminePathway InteractionsDiagnosisCancer CellLeadResistancePublicationsBase
Grant awards (9)
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis$700,207
R01 · FY2017 · CA
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis$704,248
R01 · FY2016 · CA
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis$712,729
R01 · FY2015 · CA · contact PI
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis$751,274
R01 · FY2014 · CA · contact PI
Validation of Biomarkers to Distinguish Aggressive from Indolent Prostate Cancer$161,318
R21 · FY2014 · CA · contact PI
Androgen Receptor-JunD Complex Inhibitors to Prevent Prostate Cancer Progression$300,000
R43 · FY2012 · CA · contact PI
Mitochondria Targeted Anti-oxidant for Treatment of Prostate Cancer$109,558
R43 · FY2008 · CA · contact PI
Prostate-Directed Antioxidant to Prevent Prostate Cancer$71,369
R03 · FY2007 · CA · contact PI
Prostate-Directed Antioxidant to Prevent Prostate Cancer$73,500
R03 · FY2006 · CA · contact PI